Michael Fröhner

Title: Michael Fröhner: Innovator in Prostate Cancer Diagnostics

Introduction

Michael Fröhner is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of prostate cancer. With a total of 4 patents to his name, Fröhner's work focuses on the development of RNA-biomarkers that enhance the accuracy of cancer screening.

Latest Patents

Fröhner's latest patents revolve around RNA-biomarkers for the diagnosis of prostate cancer. His inventions relate to the identification and selection of differentially expressed transcripts in tumor cells. The specific determination of these biomarkers can be utilized for effective screening and diagnosis of prostate cancer. The clinical application of assays based on these biomarkers aims to reduce the high number of false positives associated with current standard screening methods.

Career Highlights

Michael Fröhner is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to focus on innovative solutions in medical diagnostics, contributing to advancements in cancer detection.

Collaborations

Fröhner has collaborated with esteemed colleagues such as Jörg Hackermüller and Kristin Reiche. These partnerships have fostered a collaborative environment that enhances the research and development of effective diagnostic tools.

Conclusion

Michael Fröhner's contributions to the field of prostate cancer diagnostics through his innovative patents highlight his commitment to improving medical screening processes. His work not only advances scientific knowledge but also has the potential to significantly impact patient care.